China Medical & HealthCare Group Limited
COLRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,627 | $1,569 | $1,439 | $1,477 |
| % Growth | 3.7% | 9% | -2.6% | – |
| Cost of Goods Sold | $1,303 | $1,283 | $1,277 | $1,301 |
| Gross Profit | $325 | $286 | $162 | $176 |
| % Margin | 19.9% | 18.2% | 11.2% | 11.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $224 | $231 | $255 | $223 |
| SG&A Expenses | $231 | $237 | $259 | $225 |
| Sales & Mktg Exp. | $7 | $6 | $4 | $3 |
| Other Operating Expenses | -$2 | -$34 | -$201 | -$197 |
| Operating Expenses | $238 | $203 | $201 | $197 |
| Operating Income | $86 | $83 | -$39 | -$21 |
| % Margin | 5.3% | 5.3% | -2.7% | -1.4% |
| Other Income/Exp. Net | -$29 | -$48 | -$59 | -$58 |
| Pre-Tax Income | $57 | $35 | -$117 | -$110 |
| Tax Expense | $15 | $15 | $2 | $17 |
| Net Income | $29 | $11 | -$124 | -$137 |
| % Margin | 1.8% | 0.7% | -8.6% | -9.3% |
| EPS | 0.027 | 0.012 | -0.17 | -0.19 |
| % Growth | 117.2% | 107.2% | 10.5% | – |
| EPS Diluted | 0.027 | 0.012 | -0.17 | -0.19 |
| Weighted Avg Shares Out | 1,086 | 924 | 732 | 732 |
| Weighted Avg Shares Out Dil | 1,086 | 924 | 732 | 732 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32 | $24 | $4 | $1 |
| Interest Expense | $29 | $48 | $59 | $58 |
| Depreciation & Amortization | $97 | $98 | $105 | $105 |
| EBITDA | $183 | $175 | $47 | $52 |
| % Margin | 11.3% | 11.1% | 3.2% | 3.5% |